Suppr超能文献

腹腔镜保留肝实质的再次肝切除术治疗转移性结直肠癌患者的长期肿瘤学结果:一项欧洲多中心研究。

Long-term oncological outcomes after laparoscopic parenchyma-sparing redo liver resections for patients with metastatic colorectal cancer: a European multi-center study.

机构信息

The Intervention Centre, Oslo University Hospital, Rikshospitalet, Norway.

Department of Acute and Digestive Surgery, Haukeland University Hospital, Bergen, Norway.

出版信息

Surg Endosc. 2022 May;36(5):3374-3381. doi: 10.1007/s00464-021-08655-z. Epub 2021 Aug 30.

Abstract

BACKGROUND

Laparoscopic redo resections for colorectal metastases are poorly investigated. This study aims to explore long-term results after second, third, and fourth resections.

MATERIAL AND METHODS

Prospectively updated databases of primary and redo laparoscopic liver resections in six European HPB centers were analyzed. Procedure-related overall survival after first, second, third, and fourth resections were evaluated. Furthermore, patients without liver recurrence after first liver resection were compared to those with one redo, two or three redo, and patients with palliative treatment for liver recurrence after first laparoscopic liver surgery. Survival was calculated both from the date of the first liver resection and from the date of the actual liver resection. In total, 837 laparoscopic primary and redo liver resections performed in 762 patients were included (630 primary, 172 first redo, 29 second redo, and 6 third redo). Patients were bunched into four groups: Group 1-without hepatic recurrence after primary liver resection (n = 441); Group 2-with liver recurrence who underwent only one laparoscopic redo resection (n = 154); Group 3-with liver recurrence who underwent two laparoscopic redo resections (n = 29); Group 4-with liver recurrence who have not been found suitable for redo resections (n = 138).

RESULTS

No significant difference has been found between the groups in terms of baseline characteristics and surgical outcomes. Rate of positive resection margin was higher in the group with palliative recurrence (group 4). Five-year survival calculated from the first liver resection was 67%, 62%, 84%, and 7% for group 1, 2, 3, and 4, respectively. Procedure-specific 5-year overall survival was 50% after primary laparoscopic liver resection, 52% after the 1st reoperation, 52% after the 2nd, and 40% after the 3rd reoperation made laparoscopic.

CONCLUSIONS

Multiple redo recurrences can be performed laparoscopically with good long-term results. Liver recurrence does not aggravate prognosis as long as the patient is suitable for reoperation.

摘要

背景

腹腔镜结直肠转移灶再次切除术的研究较少。本研究旨在探讨第二次、第三次和第四次切除术后的长期结果。

材料与方法

分析了 6 个欧洲肝胆胰中心的原发性和腹腔镜肝再切除术的前瞻性更新数据库。评估了第一次、第二次、第三次和第四次手术后与手术相关的总生存率。此外,将首次腹腔镜肝切除术后无肝复发的患者与首次腹腔镜肝切除术后仅行一次腹腔镜再切除、两次或三次腹腔镜再切除、以及行姑息性治疗的患者进行比较。生存时间从第一次肝切除术的日期和实际肝切除术的日期计算。共纳入 762 例患者的 837 例腹腔镜原发性和再切除术(630 例原发性,172 例首次再切除,29 例二次再切除,6 例三次再切除)。患者分为四组:第 1 组为原发性肝切除术后无肝复发(n=441);第 2 组为仅行一次腹腔镜再切除的肝复发患者(n=154);第 3 组为行两次腹腔镜再切除的肝复发患者(n=29);第 4 组为肝复发且不适合再切除的患者(n=138)。

结果

各组在基线特征和手术结果方面无显著差异。姑息性复发组(第 4 组)的阳性切缘率较高。从第一次肝切除术开始计算的 5 年生存率分别为第 1 组、第 2 组、第 3 组和第 4 组的 67%、62%、84%和 7%。原发性腹腔镜肝切除术后 5 年的手术特异性总生存率为 50%,第 1 次再手术为 52%,第 2 次再手术为 52%,第 3 次再手术为 40%。

结论

腹腔镜多次再复发可获得良好的长期效果。只要患者适合再次手术,肝复发并不加重预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb81/9001231/7caeb5b87a75/464_2021_8655_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验